SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001013762-21-000225
Filing Date
2021-10-05
Accepted
2021-10-05 11:40:05
Documents
2
Period of Report
2021-10-05

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea148409-6k_tizianalife.htm 6-K 14917
2 REGULATORY NEWS SERVICE ANNOUNCEMENT, DATED OCTOBER 5, 2021 ea148409ex99-1_tizianalife.htm EX-99.1 16488
  Complete submission text file 0001013762-21-000225.txt   32438
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 211305586
SIC: 2834 Pharmaceutical Preparations